Whole pelvis irradiation improves biochemical progression-free survival in high-risk prostate cancer patients treated with external beam radiotherapy and high dose rate (HDR) brachytherapy.
Affiliation
Mount Vernon Cancer Centre, Northwood, UKIssue Date
2018-03
Metadata
Show full item recordCitation
Whole pelvis irradiation improves biochemical progression-free survival in high-risk prostate cancer patients treated with external beam radiotherapy and high dose rate (HDR) brachytherapy. 2018, 30(3):195 Clinical OncologyJournal
Clinical OncologyDOI
10.1016/j.clon.2017.12.011Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0936655517305307Type
Meetings and ProceedingsLanguage
enISSN
09366555ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2017.12.011